RCEEX | TIBRX | RCEEX / TIBRX | |
Total Expense Ratio | 1.07 | 1.54 | 69% |
Annual Report Gross Expense Ratio | 1.07 | 1.72 | 62% |
Fund Existence | 11 years | 21 years | - |
Gain YTD | 14.211 | 25.064 | 57% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 118B | 17.3B | 682% |
Annual Yield % from dividends | 2.57 | 3.50 | 74% |
Returns for 1 year | 12.01 | 25.35 | 47% |
Returns for 3 years | 28.08 | 62.06 | 45% |
Returns for 5 years | 45.55 | 93.52 | 49% |
Returns for 10 years | 49.86 | 108.12 | 46% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 22.95 | 0.38 | +1.68% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
EWQ | 43.89 | 0.39 | +0.90% |
iShares MSCI France ETF | |||
PBJN | 28.97 | 0.18 | +0.62% |
PGIM S&P 500 Buffer 20 ETF - Jun | |||
GLU | 17.84 | 0.05 | +0.28% |
Gabelli Utility & Income Trust (The) | |||
SLQD | 50.62 | 0.01 | +0.02% |
iShares 0-5 Year Invmt Grade Corp Bd ETF |